Viz RV/LV vs Eko Low Ejection Fraction Tool (ELEFT)

Both tools demonstrate strong usability within their respective clinical contexts. Viz RV/LV streamlines complex imaging analysis and care coordination for acute conditions, integrating into existing hospital systems and mobile workflows. Eko ELEFT offers rapid, non-invasive screening at the point of care during routine physical exams, providing results in approximately 15 seconds, making advanced diagnostics accessible to primary care.

Both tools offer substantial clinical value by addressing critical cardiac conditions with FDA-cleared AI. Viz RV/LV has demonstrated a significant 74% reduction in in-hospital mortality risk for PE patients by accelerating diagnosis and care coordination. Eko ELEFT enables early, non-invasive detection of low ejection fraction and valvular heart disease in primary care, which is crucial for timely intervention and management of heart failure.

Both companies employ non-public, enterprise-level subscription pricing models, making a direct cost comparison impossible. While Viz.ai has documented CMS reimbursement through the NTAP program for some of its AI solutions, Eko's SENSORA platform, which includes ELEFT, has also received CMS recognition for payment rates. Without specific pricing details or comparative ROI studies for these particular tools, a clear winner cannot be determined.

Both tools demonstrate high enterprise readiness with FDA clearance, HIPAA compliance, BAAs, and cloud-based deployments. Both companies also hold relevant security certifications (SOC 2 for both, ISO for both) and integrate into broader platforms (Viz PE Solution, Eko SENSORAu2122). Their extensive deployments and certifications indicate robust capabilities for large-scale healthcare system integration.

Both tools represent significant innovation in healthcare AI. Viz RV/LV excels in automating complex imaging analysis and integrating it into an acute care coordination workflow for rapid response to critical conditions, earning multiple Edison Awards. Eko ELEFT innovates by embedding sophisticated AI diagnostics into a common, non-invasive device for early detection of chronic conditions in primary care, democratizing access to advanced cardiac screening and receiving awards like Fast Company's World Changing Ideas.

Viz.ai explicitly details a comprehensive customer support structure, including a dedicated customer success team, clinical and workflow specialists, and clinical research scientists to assist with implementation, training, and achieving specific goals. They also offer various resources and direct contact methods. While Eko Health provides a help center and regulatory documentation, the depth of proactive customer success and workflow optimization support appears more thoroughly articulated for Viz.ai.